USP22 and cancer: A study demonstrated that recombinant PR domain containing protein 1/B lymphocyte-induced maturation protein 1 orchestrates cancer immune evasion in HCC cells by regulating the ubiquitin specific peptidase 22-SPI1-PD-L1 axis [32].